marijuana stocks news

22nd Century’s Fox Business Network Appearance Rescheduled

22nd Century Group, Inc. (NYSE MKT: XXII), a leader in very low nicotine tobacco technology and tobacco harm reduction, today announced that due to the extensive coverage of the ongoing Baltimore unrest, the previously announced interview of 22nd Century’s President and Chief Executive Officer, Henry Sicignano III, by Stuart Varney of Fox Business’ “Varney & Co” has been moved from today to Wednesday, April 29, 2015 at 12:50 p.m. EDT.

Revised Varney & Co. with Stuart Varney programming details are as follows:

Date: Wednesday, April 29, 2015
Start Time: 12:50 p.m. EDT
Live TV: Fox Business Network

About 22nd Century Group, Inc.

22nd Century Group is a plant biotechnology company focused on technology which allows it to increase or decrease the level of nicotine in tobacco plants through genetic engineering and plant breeding. The Company’s mission is to reduce the harm caused by smoking. 22nd Century owns or exclusively controls 128 issued patents plus an additional 52 pending patent applications in 96 countries. The Company’s strong IP position led to a licensing agreement with British American Tobacco (“BAT”), the world’s second largest tobacco company. Visitwww.xxiicentury.com for more information.

Contact:
Investor Relations:
IRTH Communications
Andrew Haag, 866-976-4784
xxii@irthcommunications.com
or
Redington, Inc.
Tom Redington, 203-222-7399

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$EDXC CEO Todd Davis Featured on Dr. Ronald Hoffman’s Intelligent Medicine(TM)

Endexx CEO Todd Davis Featured on Dr. Ronald Hoffman’s Intelligent Medicine(TM) Endexx…

$PZOO Signs Deal With New Consulting Company, Luchesi & Brand LLC

Pazoo Signs Deal With New Consulting Company, Luchesi & Brand LLC Pazoo,…

$PZOO Definitive Agreement

Pazoo Wholly Owned Subsidiary, Harris Lee, LLC Enters Into Definitive Agreement With…

$GWPH at The Goldman Sachs 37th Annual Global Healthcare Conference

GW Pharmaceuticals to Present at the Goldman Sachs 37th Annual Global Healthcare…